- August 26, 2026
SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million...
Read more » - May 9, 2026
We ask the Omaze founder: Is there such a thing as a free house?
Omaze founder: ‘People still think it’s a scam’ Matt Pohlson insists his...
Read more »
Recent News
Third Pole Theraputics

In 1998, three American scientists were awarded the Nobel Prize for their identification of Nitric Oxide